Alleviating Trunk Low Back Pain, With an Active Medical Device Study (ATLAS) (ATLAS)
Primary Purpose
Chronic Low Back Pain
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
wearing ATLAS device during evaluation at 4th day
wearing ATLAS device during evaluation at 5th day
Sponsored by
About this trial
This is an interventional prevention trial for Chronic Low Back Pain focused on measuring Low back pain, Medical device, Spine, Rehabilitation, Traction
Eligibility Criteria
Inclusion Criteria:
- Chronic low back pain for more than 3 month
- Analogical visual scale superior or egal to 3/10
- BMI < 30
- 18 < Age < 75 years
- Patients who signed the informed consent
- Hospital Anxiety and depression score less than 11
Exclusion Criteria:
- - Neurological or radicular deficit
- Skin pathology of the trunk region
- Antecedent of surgery of spinal fusion
- Implanted neurostimulation treatment
- Scoliosis with Cobb angle > 30°
- History of vertebral fracture
- BMI > 30
- Respiratory failure
- Recent rib fracture (less than 3 month)
- Pregnancy or breastfeeding
- Osteoporosis
- Refusal to participate to the study
Sites / Locations
- Hôpital Swynghedau, CHU
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Group A
Group B
Arm Description
Wearing the ATLAS device 60 min per day during 5 days and evaluation of pain during standardized activities with the ATLAS Device at the 4th day and without the device at the 5th day of a 4 weeks rehabilitation program.
Wearing the ATLAS device 60 min per day during 5 days and evaluation of pain during standardized activities without the ATLAS Device at the 4th day and with the device at the 5th day of a 4 weeks rehabilitation program.
Outcomes
Primary Outcome Measures
Pain release with the ATLAS device during standardized daily activities
Pain intensity evaluation with a 100 mm Visual Analogue Scale (VAS) from 0 to 100 mm (0 means no pain and 100 means extremely severe pain) during the standardized daily activities (the most intense pain reported during the 5 activities is recorded).
Secondary Outcome Measures
Pain release with the ATLAS device during standardized daily activities
Pain intensity evaluation with a 100 mm Visual Analogue Scale (VAS) from 0 to
Percentage of improved patients
Percentage of patients reporting pain improvement of at least 20 mm on the Visual Analogue Scale with the ATLAS device during the 5 standardized daily activities compared to the pain reported without wearing the ATLAS device during the same 5 standardized daily activities (the most intense pain reported during the 5 activities is recorded).
Percentage of patients relieved with the ATLAS device
Percentage of patients wearing the ATLAS device reporting pain intensity less than 30 mm on a 100mm Visual Analogue scale during the 5 standardized daily activities (the most intense pain reported during the 5 activities is recorded).
Full Information
NCT ID
NCT03801941
First Posted
January 3, 2019
Last Updated
February 28, 2022
Sponsor
University Hospital, Lille
Collaborators
JAPET MEDICAL DEVICE
1. Study Identification
Unique Protocol Identification Number
NCT03801941
Brief Title
Alleviating Trunk Low Back Pain, With an Active Medical Device Study (ATLAS)
Acronym
ATLAS
Official Title
Cross Over Pilot Study for Evaluation of Pain Reduction in Patients With Chronic Low Back Pain (for More Than 3 Month) Using an Innovative Handheld Device
Study Type
Interventional
2. Study Status
Record Verification Date
February 2022
Overall Recruitment Status
Completed
Study Start Date
April 1, 2019 (Actual)
Primary Completion Date
June 30, 2021 (Actual)
Study Completion Date
June 30, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Lille
Collaborators
JAPET MEDICAL DEVICE
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of the study is to evaluate the reduction of pain by wearing the ATLAS Medical Device in standardized daily activities for patients with Chronic Low Back Pain.
This is an intervention al non blinded study with a crossover design comparing pain evaluated with an Analogue Visual Scale with and without the ATLAS device during 5 standardized daily activities.
Detailed Description
This study aims at assessing pain release by wearing a new medical device (ATLAS) in patients affected by chronic low back pain.
Population: patients with chronic low back pain admitted for a 4 weeks rehabilitation program.
Intervention: active rehabilitation and wearing the ATLAS device 60 min per day. The ATLAS study is carried out during the 5 first days of the rehabilitation program.
Primary outcome: Pain intensity evaluation with a 100 mm Visual Analogue Scale (VAS) during 5 standardized activities (the most intensive pain during the 5 activities is recorded), with and without wearing the ATLAS device.
Secondary outcome measures: percentage of patients reporting pain decrease of at least 20 mm on the 100 mm VAS during the 5 standardized activities with the ATLAs device compared without wearing the device. Percentage of relieved patients (percentage of patient reporting pain intensity less than 30 mm on the 100 mm VAS with wearing the device). Pain intensity evaluated with the 100 mm VAS before and after 60 min of wearing the ATLAS device.
Randomization: two groups (i.e. group A and B). Primary outcome is evaluated at day 4 and 5, with a crossover design (Group A: pain is evaluated during activities with the device at day 4 and without the device at day 5. Group B: pain is evaluated during activities without the device at day 4 and with the device at day 5).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Low Back Pain
Keywords
Low back pain, Medical device, Spine, Rehabilitation, Traction
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
32 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Group A
Arm Type
Experimental
Arm Description
Wearing the ATLAS device 60 min per day during 5 days and evaluation of pain during standardized activities with the ATLAS Device at the 4th day and without the device at the 5th day of a 4 weeks rehabilitation program.
Arm Title
Group B
Arm Type
Experimental
Arm Description
Wearing the ATLAS device 60 min per day during 5 days and evaluation of pain during standardized activities without the ATLAS Device at the 4th day and with the device at the 5th day of a 4 weeks rehabilitation program.
Intervention Type
Device
Intervention Name(s)
wearing ATLAS device during evaluation at 4th day
Intervention Description
Wearing the ATLAS device 60 min per day during 5 days and evaluation of pain during standardized activities with or without ATLAS Device at the 4th or 5th day of a 4 weeks rehabilitation program.
Intervention Type
Other
Intervention Name(s)
wearing ATLAS device during evaluation at 5th day
Intervention Description
Wearing the ATLAS device 60 min per day during 5 days and evaluation of pain during standardized activities without ATLAS Device at the 4th or 5th day of a 4 weeks rehabilitation program.
Primary Outcome Measure Information:
Title
Pain release with the ATLAS device during standardized daily activities
Description
Pain intensity evaluation with a 100 mm Visual Analogue Scale (VAS) from 0 to 100 mm (0 means no pain and 100 means extremely severe pain) during the standardized daily activities (the most intense pain reported during the 5 activities is recorded).
Time Frame
at 5th day of a 4 weeks rehabilitation program.
Secondary Outcome Measure Information:
Title
Pain release with the ATLAS device during standardized daily activities
Description
Pain intensity evaluation with a 100 mm Visual Analogue Scale (VAS) from 0 to
Time Frame
at day the 1st , 4th day of a 4 weeks rehabilitation program.
Title
Percentage of improved patients
Description
Percentage of patients reporting pain improvement of at least 20 mm on the Visual Analogue Scale with the ATLAS device during the 5 standardized daily activities compared to the pain reported without wearing the ATLAS device during the same 5 standardized daily activities (the most intense pain reported during the 5 activities is recorded).
Time Frame
at day the 1st , 4th and 5th day of a 4 weeks rehabilitation program.
Title
Percentage of patients relieved with the ATLAS device
Description
Percentage of patients wearing the ATLAS device reporting pain intensity less than 30 mm on a 100mm Visual Analogue scale during the 5 standardized daily activities (the most intense pain reported during the 5 activities is recorded).
Time Frame
at day the 1st , 4th and 5th day of a 4 weeks rehabilitation program.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Chronic low back pain for more than 3 month
Analogical visual scale superior or egal to 3/10
BMI < 30
18 < Age < 75 years
Patients who signed the informed consent
Hospital Anxiety and depression score less than 11
Exclusion Criteria:
- Neurological or radicular deficit
Skin pathology of the trunk region
Antecedent of surgery of spinal fusion
Implanted neurostimulation treatment
Scoliosis with Cobb angle > 30°
History of vertebral fracture
BMI > 30
Respiratory failure
Recent rib fracture (less than 3 month)
Pregnancy or breastfeeding
Osteoporosis
Refusal to participate to the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vincent Tiffreau, MD,PhD
Organizational Affiliation
University Hospital, Lille
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hôpital Swynghedau, CHU
City
Lille
Country
France
12. IPD Sharing Statement
Learn more about this trial
Alleviating Trunk Low Back Pain, With an Active Medical Device Study (ATLAS)
We'll reach out to this number within 24 hrs